Evidence map›Paper›PMID 23512943›Full record

ArticleObesity (Silver Spring, Md.)2013

Effects of sugar-sweetened beverages on plasma acylation stimulating protein, leptin and adiponectin: relationships with metabolic outcomes.

Reza Rezvani, Katherine Cianflone, John P McGahan, Lars Berglund, Andrew A Bremer, Nancy L Keim, Steven C Griffen, Peter J Havel, Kimber L Stanhope

Open access · bronzeAbstract read
In one paragraph

Article in Obesity (Silver Spring, Md.), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Tolerable upper intake level for dietary sugars.EFSA journal. European Food Safety Authority · 2022
    Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Pathophysiology of Non Alcoholic Fatty Liver Disease.International journal of molecular sciences · 2016
    Review
  19. Sugar consumption, metabolic disease and obesity: The state of the controversy.Critical reviews in clinical laboratory sciences · 2016
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Reza RezvaniInstitut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University, Québec, Quebec, Canada.
Katherine Cianflone
John P McGahan
Lars Berglund
Andrew A Bremer
Nancy L Keim
Steven C Griffen
Peter J Havel
Kimber L Stanhope
University of California, Davis · USInstitut universitaire de cardiologie et de pneumologie de Québec · CAUnited States Department of Agriculture · USUniversité Laval · CAUniversity of California Davis Medical Center · US

Funding

UC DAVIS CLINICAL AND TRANSLATIONAL SCIENCE CENTER: BPCAUL1RR024146 · NCRR · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BERGLUND, LARS F · 2006 to 2011
$27.0M
Building Interdisciplinary Research Careers in Womens Health at UC Davis - Administrative SupplementK12HD051958 · NICHD · UNIVERSITY OF CALIFORNIA DAVIS · PI LANE, NANCY E · 2005 to 2023
$9.6M
Effects of 2wk fructose & HFCS consumption on lipid dysregulation & insulin resisR01HL091333 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HAVEL, PETER J · 2008 to 2012
$2.0M
Dietary Fructose: Hormones &TG/Lipoprotein MetabolismR01HL075675 · NHLBI · UNIVERSITY OF CALIFORNIA DAVIS · PI HAVEL, PETER J · 2004 to 2008
$1.8M
Fatty acid sources of fructose and HFCS-induced postprandial hypertriglyceridemiaR01HL107256 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HAVEL, PETER J, SCHWARZ, JEAN-MARC · 2011 to 2014
$1.5M
CIHRNCRR NIH HHS UL1 RR024146NHLBI NIH HHS R01 HL-075675NHLBI NIH HHS R01 HL075675NHLBI NIH HHS R01 HL091333NHLBI NIH HHS R01 HL107256NICHD NIH HHS K12 HD051958
6 · The paper itself

Abstract

objectiveThe effects of fructose and glucose consumption on plasma acylation stimulating protein (ASP), adiponectin, and leptin concentrations relative to energy intake, body weight, adiposity, circulating triglycerides, and insulin sensitivity were determined. DESIGN AND

methodsThirty two overweight/obese adults consumed glucose- or fructose-sweetened beverages (25% energy requirement) with their ad libitum diets for 8 weeks, followed by sweetened beverage consumption for 2 weeks with a standardized, energy-balanced diet. Plasma variables were measured at baseline, 2, 8, and 10 weeks, and body adiposity and insulin sensitivity at baseline and 10 weeks.

resultsFasting and postprandial ASP concentrations increased at 2 and/or 8 weeks. ASP increases correlated with changes in late-evening triglyceride concentrations. At 10 weeks, fasting adiponectin levels decreased in both groups, and decreases were inversely associated with baseline intra-abdominal fat volume. Sugar consumption increased fasting leptin concentrations; increases were associated with body weight changes. The 24-h leptin profiles increased during glucose consumption and decreased during fructose consumption. These changes correlated with changes of 24-h insulin levels.

conclusionsThe consumption of fructose and glucose beverages induced changes in plasma concentrations of ASP, adiponectin, and leptin. Further study is required to determine if these changes contribute to the metabolic dysfunction observed during fructose consumption.

Indexed as

BeveragesAdiponectinAdiposityAdultAgedBlood GlucoseBody WeightComplement C3DietEnergy IntakeFemaleFructoseHumansInsulinInsulin ResistanceIntercellular Signaling Peptides and ProteinsAdiponectinBlood GlucoseC3 protein, humanComplement C3FructoseInsulinIntercellular Signaling Peptides and ProteinsLeptinNutritive SweetenersTriglycerides

Identifiers

PMID23512943
PMCPMC3732502
OpenAlexW1578040554

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.